Drugs often rival angioplasty, study finds
AP/San Francisco Chronicle, August 15, 2008
There is now more evidence that drugs should be tried first and often are just as effective in patients with chronic chest pain who are not in big danger of a heart attack. The slim early advantage for angioplasty at relieving pain in these nonemergency cases starts to fade within six months and vanishes after three years, according to a report from a landmark heart study. That is sooner than the five years doctors estimated in 2007 after their first analysis of the study.
Most Viewed
Most Emailed
- $6.4B Henry Ford, Beaumont Merger Failed on Cultural Hurdles
- Fortunately, Angelina Jolie Isn't On Medicare
- Don't Let Nurses Sink Your Bottom Line
- House Lawmakers Grill CMS Over Health Exchange Navigators
- How Chargemaster Data May Affect Hospital Revenue
- Hospital Pricing Transparency a Marketing Game Changer
- Hospitals Profit On Bloodstream Infections
- Primary Care Docs Average More Hospital Revenue Than Specialists
- Less Blood Testing for Some Surgeries Safe, Cost Effective
- ED Physicians Key to Half of Hospital Admissions
